Altria Group (MO) 62.66 $MO Which 3 Top Stocks Are Near

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Altria Group (MO) 62.66 $MO

Which 3 Top Stocks Are Near Their Buy Points?
at Investor's Business Daily - Thu Mar 31, 2:27PM CDT
Three of the four Sector Leaders are retailers. Another sector that's been holding up well is alcohol and tobacco, ranked No. 8 in Thursday's IBD. Constellation Brands (STZ) is nearing a 155.78 buy point of a lopsided cup base. The correction from...
RAI: 50.31 (-0.17), BUD: 124.66 (-1.08), STZ: 151.09 (-0.51), MO: 62.66 (+0.08)

Altria (MO) Stock Gains on S&P Credit Ratings Upgrade
at The Street - Wed Mar 30, 2:41PM CDT
Altria (MO) stock is rising in late afternoon trading on Wednesday after Standard & Poor's Ratings Services upgraded all of the company's credit ratings.
MO: 62.66 (+0.08)

Reynolds Shares Smoking On Newport, Tobacco’s Comeback
at Investor's Business Daily - Wed Mar 30, 2:35PM CDT
What a difference a brand can make. Just ask big-tobacco company Reynolds American (RAI), now on a roll with its newly acquired Newport, the No. 2 cigarette in the U.S. behind Marlboro and the nation’s No. 1 menthol brand. Even as tobacco consumption...
RAI: 50.31 (-0.17), BTI: 116.91 (-0.07), MO: 62.66 (+0.08)

Stock Market News for March 29, 2016
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 9:10AM CDT
Benchmarks closed mixed on Monday after gains in consumer staples and consumer discretionary stocks were partly offset by losses in energy stocks
RAI: 50.31 (-0.17), KO: 46.39 (-0.19), NBL: 31.41 (+0.63), COP: 40.27 (+0.19), DIS: 99.31 (+0.40), MO: 62.66 (+0.08), MAR: 71.18 (-0.37), TWX: 72.55 (+0.39), NFLX: 102.23 (+0.04), SBUX: 59.70 (-0.31), PXD: 140.74 (+0.33), TSO: 86.01 (-0.46), KHC: 78.56 (-0.34), COST: 157.58 (-0.02), OXY: 68.43 (-0.17)

Costco Wholesale Follows CVS Health Corp.'s Lead With Cigarettes -- Sort Of
James Sullivan, The Motley Fool - Motley Fool - Mon Mar 28, 12:00PM CDT
COSTCO DOESN'T NEED CIGARETTES TO GET CUSTOMERS INTO ITS STORES. IMAGE SOURCE: COSTCO. The tobacco industry in the U.S. has withstood decades of lawsuits, health labeling requirements, and changing consumer preferences. Its biggest player,  Altria...
CVS: 103.73 (-0.32), COST: 157.58 (-0.02), MO: 62.66 (+0.08)

4 Things Philip Morris International Inc. Investors Should Notice
Leo Sun, The Motley Fool - Motley Fool - Mon Mar 28, 8:19AM CDT
Shares of Philip Morris International have rallied nearly 10% since the beginning of the year, easily outperforming the S&P 500's 1% decline. But after that run, some investors might be wondering if the tobacco stock is getting ahead of its...
RAI: 50.31 (-0.17), PM: 98.11 (-0.58), MO: 62.66 (+0.08)

AAPL, GOOGL, NKE, UA: Jim Cramer's Views
at The Street - Mon Mar 28, 12:00AM CDT
Jim Cramer shares his views on pricing power and snap judgments. Apple, Google, Nike and Under Armour are among the stocks discussed here.
MNK: 61.28 (+1.37), VRX: 26.30 (-0.77), NKE: 61.47 (-0.57), FB: 114.10 (-0.60), MO: 62.66 (+0.08), PLKI: 52.06 (+0.28), JACK: 63.87 (-0.59), UA: 84.83 (-0.81), PM: 98.11 (-0.58), VAL: 107.02 (+0.45), DNKN: 47.17 (+0.19), RIG: 9.14 (+0.25), GILD: 91.86 (-0.11), MRK: 52.91 (-0.31), MCD: 125.68 (-0.15), GOOGL: 762.90 (-5.44), SHW: 284.67 (+0.24), KKD: 15.59 (+0.16), AAPL: 108.99 (-0.57)

5 Stocks That Could Be Toxic to Your Portfolio in 2016
at The Street - Sun Mar 27, 7:37PM CDT
It's time to unload these toxic stocks from your portfolio.
VRTX: 79.49 (+1.09), AGIO: 40.60 (+2.71), MO: 62.66 (+0.08), GRPN: 3.99 (+0.09), SWN: 8.07 (+0.37)

Philip Morris International Gets Upgraded -- but Altria Is Going Down
Rich Smith, The Motley Fool - Motley Fool - Thu Mar 24, 12:20PM CDT
Thursday is turning into an interesting day for investors in tobacco stocks, as Bank of America-Merrill Lynch announces a pair downgrade/upgrade on Altria stock and its former subsidiary Philip Morris International . The news Let's start...
PM: 98.11 (-0.58), MO: 62.66 (+0.08)

Altria (MO) Stock Retreats on BofA/Merrill Lynch Downgrade
at The Street - Thu Mar 24, 8:19AM CDT
Altria (MO) stock is declining in pre-market trading on Thursday after the company was downgraded to "neutral" from "buy" at BofA/Merrill Lynch.
MO: 62.66 (+0.08)

Better Buy: Altria Group Inc. vs. Philip Morris
Dan Caplinger, The Motley Fool - Motley Fool - Wed Mar 23, 4:03PM CDT
Image source: Altria Group. Tobacco stocks have performed extremely well over the years, and Altria Group and Philip Morris International are both giants in the industry. Even though the two companies share a common history, they have...
PM: 98.11 (-0.58), MO: 62.66 (+0.08)

Is Reynolds Helping Cigarette Smuggling Across Europe?
Zacks Equity Research - Zacks Investment Research - Wed Mar 23, 11:40AM CDT
The U.S. Supreme Court is debating whether the European Union (EU) should be allowed to pursue the lawsuit against Reynolds American Inc.'s (RAI) subsidiary R.J. Reynolds for drug and cigarette smuggling.
RAI: 50.31 (-0.17), PM: 98.11 (-0.58), MO: 62.66 (+0.08), VGR: 22.84 (-0.06)

Read Between Headlines and Invest in These Three Stocks
at The Street - Tue Mar 22, 4:56PM CDT
Author Matt Towery likes Northrop Grumman, Altria Group and Preferred Apartment Communities.
APTS: 12.68 (+0.04), NOC: 197.90 (-0.83), MO: 62.66 (+0.08)

Look for Shares of Altria Group to Potentially Rebound after Yesterday's 1.05% Sell Off
Comtex SmarTrend(R) - Tue Mar 22, 12:23PM CDT
Altria Group (NYSE:MO) traded in a range yesterday that spanned from a low of $61.00 to a high of $61.66. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $61.06 on volume of 1.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MO: 62.66 (+0.08)

Altria Group Falls 1.05% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Mar 22, 12:21PM CDT
Altria Group (NYSE:MO) traded in a range yesterday that spanned from a low of $61.00 to a high of $61.66. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $61.06 on volume of 1.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MO: 62.66 (+0.08)

Read This Before Investing In E-Cigarettes
Leo Sun, The Motley Fool - Motley Fool - Sun Mar 20, 8:48AM CDT
Over the past few years, many major tobacco companies have acquired or launched their own e-cigarette brands to diversify away from traditional cigarettes. Some consumers buy e-cigarettes as "healthier" alternatives to regular cigarettes, but critics...
RAI: 50.31 (-0.17), PM: 98.11 (-0.58), BTI: 116.91 (-0.07), MO: 62.66 (+0.08)

Are Altria Group Inc. and Reynolds American Inc. Getting Overvalued?
Leo Sun, The Motley Fool - Motley Fool - Fri Mar 18, 10:12AM CDT
Shares of Altria and Reynolds American , the two biggest domestic tobacco companies, respectively rallied about 20% and 45% over the past 12 months. Both stocks...
RAI: 50.31 (-0.17), MO: 62.66 (+0.08)

Will India Go Easy on Tobacco Primes to Check Illicit Trade?
Zacks Equity Research - Zacks Investment Research - Tue Mar 15, 1:05PM CDT
Tobacco companies have been penalized for taking recourse to any kind of advertising or packaging to boost sales that flout the laws.
RAI: 50.31 (-0.17), PM: 98.11 (-0.58), MO: 62.66 (+0.08)

These 5 Big Sin Stocks Are Breaking Out Right Now
at The Street - Tue Mar 15, 5:51AM CDT
The technical setups in these five sin stocks are showing solid upside potential right now.
BUD: 124.66 (-1.08), MO: 62.66 (+0.08), MGM: 21.44 (+0.15), DEO: 107.87 (-0.83), SWHC: 26.62 (-0.38)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CaliberMRI Revolutionizes Preclinical MRI with New Phantom

Updated Category News Views 107

CaliberMRI: Pioneers Shaping the Future of MRI Hot off the press, folks—CaliberMRI, known for setting the bar high in MRI standardization, has unleashed a new beast on the scene. Enter Model 340, a preclinical quantitative MRI phantom, ready to knock the socks off high-field systems. They’re talking 4.7T, 7T, and a jaw-dropping 9.4T compatibility here. This isn't just...

Continue Reading
LINE-X Seeks Veterans to Propel Franchise Growth

Updated Category News Views 55

If you've ever wondered about the intersection of military discipline and entrepreneurial spirit, LINE-X is handing veterans the keys, quite literally. With a nod to leathernecks and GIs, they're slashing their franchise fee by 25% for U.S. veterans aiming to trade sergeants' stripes for business clout. Franchising for Veterans: A Tailored Offer So, the word on the street...

Continue Reading
Peanuts and Diabetes: A Surprising Health Link

Updated Category News Views 68

A Nutty Approach to Diabetes Prevention Who would've thought peanuts could pack such a punch against diabetes? Amid the usual suspects of healthy foods, it's these humble legumes that are making headlines. The Peanut Institute, backed by fresh research, is shining a spotlight on their potential role in preventing type 2 diabetes, a disease that's affecting roughly 40...

Continue Reading
Untapped $41B VA Loan Potential: Opportunities Missed

Updated Category News Views 106

VA Loans: Unused Potential Sits at $41 Billion Are you telling me we're leaving $41 billion just sitting on the table in the form of untapped VA loans? That's the figure staring us in the face according to Veterans United's latest analysis. It's not just about numbers; it's a head-scratcher given the growing VA loan market share, which hit 10% last year. Where's the...

Continue Reading
Key Insights Await in Sectra's Six-Month Report

Updated Category News Views 75

Sometimes the anticipation of a financial report presentation feels akin to waiting for a storm to pass or the sun to finally break through after what seems like endless rain. That’s the kind of vibe we're getting from Sectra's upcoming six-month report presentation. Slated for November 25, President Torbjörn Kronander and CFO Jessica Holmquist will be stepping up to...

Continue Reading
AI Shakes Up Boat Discovery: Traffic Soars for Leaders

Updated Category News Views 28

AI's Surge in the Boating World Well, look who’s riding the AI wave—it's our old friends at Boat Trader and YachtWorld, leaving the competition coughing in their slipstream. Similarweb data throws some cold, hard fish onto the deck, showing these two raking in over 17 times the AI-referred traffic compared to their closest peers. If you’re sniffing around for where...

Continue Reading
Accro's Vitiligo Trial Moves Fast with Fosun's Boost

Updated Category News Views 112

Launching into Vitiligo Treatment Trials I'll tell you, the biotech world isn't for the faint-hearted, especially when you're juggling hefty terms like 'TYK2/JAK1'. But here we are, watching Accro Bioscience and Fosun Pharma dive headlong into the vitiligo space with this Phase II/III trial of AC-201. They've bagged the IND clearance, and now the first patient is in the...

Continue Reading
CPC Biotech Debuts Quattroflow HTX Pump Drive

Updated Category News Views 51

Innovative Moves in Bioprocessing Let's get one thing clear right off the bat—CPC Biotech, part of Dover (NYSE: DOV), just sent a signal loud and clear with their new Quattroflow HTX all-in-one pump drive. With a slick touchscreen, flexible control options, and self-touting accuracy, this thing sounds like it's set to change the game for biopharmaceutical processing....

Continue Reading
AI Adoption Institute Targets ROI with Peer Circles

Updated Category News Views 73

Transforming AI from Cost to Profit Alright folks, we all know AI's the flashy tool everyone's jumping on like it's the latest tech bandwagon. But here’s the raw deal: most of these shiny AI investments ain't paying back a damn thing. Enter the AI Adoption Institute (AiAi)—a new player in Denver aiming to salvage this mess and make AI about actual returns. Peering...

Continue Reading
Bramshill Fund Takes Top Spot in 2026 Fund Awards

Updated Category News Views 78

Another Feather in Bramshill's Cap They've done it again, folks. The Bramshill Multi-Strategy Income Fund has just snagged the 40 Act Fund of the Year award at the 2026 Hedge Fund Performance Awards. This ain't just another plaque for the wall; it's a nod to some serious heavy lifting by the folks handling this beast of a portfolio. The award, dished out by With...

Continue Reading

Top 5 Most Recently Viewed Articles

Twilio's Q4 Results Spark Diverse Analyst Reactions

Updated Category News Views 232

Twilio Inc Fourth Quarter Overview Twilio Inc reported notable financial results for the fourth quarter, capturing the attention of several analysts within the market. The company’s performance has sparked diverse reactions, particularly regarding its future guidance and the evolving role of artificial intelligence within its operations. Market Response to Q4 Earnings...

Continue Reading
FHLBank Indianapolis Dividends for Second Quarter of 2025

Updated Category News Views 180

FHLBank Indianapolis Declares Second Quarter Dividends FHLBank Indianapolis recently announced its second quarter dividends for 2025, detailing robust financial strategies and growth, as reflected in the declared dividends on Class B-2 activity-based capital stock and Class B-1 non-activity-based stock. These dividends have been set at annualized rates of 9.50% and 4.50%,...

Continue Reading
Neurogen Biomarking Partners with Quanterix for Alzheimer's Testing

Updated Category News Views 255

Revolutionizing Alzheimer's Detection with Neurogen Biomarking Neurogen Biomarking is making significant strides in the healthcare landscape by introducing a pioneering blood test aimed at the early detection of Alzheimer's disease and Mild Cognitive Impairment (MCI). This innovative approach leverages advanced biomarker technology developed by Quanterix Corporation,...

Continue Reading
Kepler Robotics Launches Innovative Humanoid Robot for Industries

Updated Category News Views 296

Revolutionizing Industries with the K2 Bumblebee Shanghai Kepler Robotics Co., Ltd has excitedly announced the commencement of mass production of its K2 "Bumblebee" model, confirming that the world's first commercially available hybrid-architecture humanoid robot is now shipping to eager customers. Milestone in Humanoid Robotics This significant development not only marks...

Continue Reading
Syntara Limited Reveals Groundbreaking Data in Myelofibrosis Trials

Updated Category News Views 259

Positive Interim Data from Syntara's Clinical Trials Syntara Limited, known for its innovative approach in drug development, has unveiled promising interim data concerning its ongoing Phase 2 study of SNT-5505. This clinical trial focuses on myelofibrosis, a complex bone marrow disorder that often leads to severe health complications. Details of the Clinical Trial The...

Continue Reading